Results 11 to 20 of about 3,981,439 (405)

Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody

BMC Nephrology, 2021
Background Individuals with end-stage kidney disease (ESKD) on dialysis are vulnerable to contracting COVID-19 infection, with mortality as high as 31 % in this group.
Wasim Ahmed, Ali Abdul Kareem Al Obaidli, Princy Joseph, Edward R. Smith, Ayaz Ahmad Khan, Siddiq Anwar, Thangavelu Chandrasekar, Ayman Kamal Al Madani, Hormazdiar Dara Dastoor, Imran Zahid, Freddie Agbayani Costales, Yousef Abdul Rahim Boobes, Fatima Al Kindi, Salah Eldin Khalil Issa, Mohamed H. Hassan, Abraham George, Stephen Geoffrey Holt   +16 more
doaj   +1 more source

Point of Care Ultrasonography to Monitor Decongestive Therapy in Heart Failure: Seeing is Believing

POCUS Journal, 2022
Point of care ultrasonography (POCUS) is a non-invasive bedside diagnostic tool that aids in clinical decision-making process. In addition, it allows to monitor the efficacy of therapeutic interventions in real time.
Abhilash Koratala
doaj   +1 more source

Dapagliflozin in Patients with Chronic Kidney Disease.

New England Journal of Medicine, 2020
BACKGROUND Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.
H. Heerspink, B. Stefánsson, R. Correa-Rotter, G. Chertow, T. Greene, F. Hou, J. Mann, J. McMurray, M. Lindberg, P. Rossing, C. Sjöström, R. Toto, A. Langkilde, D. Wheeler   +13 more
semanticscholar   +1 more source

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2022
Background This study, the EMPA-KIDNEY trial, was designed to assess the effects of empagliflozin in a broad range of patients with chronic kidney disease (CKD) at risk of progression. Methods We randomly assigned 6609 participants to empagliflozin (10mg
W. Herrington, N. Staplin, C. Wanner, J. B. Green, S. Hauske, J. Emberson, D. Preiss, P. Judge, Kaitlin J. Mayne, S. Ng, E. Sammons, D. Zhu, M. Hill, W. Stevens, K. Wallendszus, S. Brenner, A. Cheung, Zhi-Hong Liu, Jing Li, L. Hooi, Wen Liu, T. Kadowaki, M. Nangaku, A. Levin, D. Cherney, A. Maggioni, R. Pontremoli, R. Deo, S. Goto, X. Rosselló, K. Tuttle, D. Steubl, M. Petrini, D. Massey, Jens Eilbracht, M. Brueckmann, M. Landray, C. Baigent, R. Haynes   +38 more
semanticscholar   +1 more source

Correlation of the Dietary Protein Intake between Those Estimated from a Short Protein Food-Recall Questionnaire and from 24-Hour Urinary Urea-Nitrogen Excretion in Stages 3-4 Chronic Kidney Disease Patients

International Journal of Nephrology, 2023
Introduction. High protein intake may accelerate progression of chronic kidney disease (CKD). Estimation of dietary protein intake (DPI) is indispensable for management of CKD, but to achieve optimum DPI is quite challenging in routine clinical practice.
Teerawat Thanachayanont, Methee Chanpitakkul, Akhathai Saetie, Salyaveth Lekagul, Kriang Tungsanga   +4 more
doaj   +1 more source

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association

Circulation, 2023
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The
C. Ndumele, I. Neeland, Katherine Tuttle, Sheryl L Chow, Roy O Mathew, Sadiya S. Khan, J. Coresh, C. Baker-Smith, M. Carnethon, Jean-Pierre Després, Jennifer E Ho, Joshua J Joseph, Walter N Kernan, Amit Khera, Mikhail N. Kosiborod, Carolyn L. Lekavich, Eldrin F. Lewis, Kevin B Lo, Bige Ozkan, Latha P. Palaniappan, Sonali S Patel, Michael J. Pencina, Tiffany Powell-wiley, Laurence S Sperling, Salim S. Virani, Jackson T Wright, Radhika Rajgopal Singh, Mitchell S. V. Elkind, J. Rangaswami   +28 more
semanticscholar   +1 more source

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Diabetes Care, 2022
People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent clinical trials support new approaches to treat diabetes and CKD.
I. D. de Boer, K. Khunti, Tami Sadusky, K. Tuttle, Joshua J. Neumiller, Connie M. Rhee, Sylvia E. Rosas, P. Rossing, G. Bakris   +8 more
semanticscholar   +1 more source

Kidney: polycystic kidney disease [PDF]

WIREs Developmental Biology, 2014
Polycystic kidney disease (PKD) is a life‐threatening genetic disorder characterized by the presence of fluid‐filled cysts primarily in the kidneys. PKD can be inherited as autosomal recessive (ARPKD) or autosomal dominant (ADPKD) traits. Mutations in either the PKD1 or PKD2 genes, which encode polycystin 1 and polycystin 2, are the underlying cause of
Gregory B. Vanden Heuvel, Gregory B. Vanden Heuvel, Binu M. Paul   +2 more
openaire   +3 more sources

Incidentalomas Among Healthy Nephrology Fellow Volunteers at POCUS Workshops: A Case Series

POCUS Journal, 2022
A radiographic incidental finding (sometimes called an incidentaloma) is defined as a structure that is unintentionally found during an exam for an unrelated indication.
Ira Blau, Behdad Besharatian, Nathaniel Reisinger   +2 more
doaj   +1 more source

Seasonal mortality trends for hospitalised patients with acute kidney injury across England

BMC Nephrology, 2023
Background Incidence of acute kidney injury (AKI) is known to peak in winter months. This is likely influenced by seasonality of commonly associated acute illnesses.
Esther Wong, Javeria Peracha, David Pitcher, Anna Casula, Retha Steenkamp, James F Medcalf, Dorothea Nitsch   +6 more
doaj   +1 more source